Literature DB >> 19401391

Src family kinases are necessary for cell migration induced by extracellular HMGB1.

Roberta Palumbo1, Francesco De Marchis, Tobias Pusterla, Antonio Conti, Massimo Alessio, Marco E Bianchi.   

Abstract

HMGB1 is a nuclear protein that signals tissue damage, as it is released by cells dying traumatically or secreted by activated innate immunity cells. Extracellular HMGB1 elicits the migration to the site of tissue damage of several cell types, including inflammatory cells and stem cells. The identity of the signaling pathways activated by extracellular HMGB1 is not known completely: We reported previously that ERK and NF-kappaB pathways are involved, and we report here that Src is also activated. The ablation of Src or inhibition with the kinase inhibitor PP2 blocks migration toward HMGB1. Src associates to and mediates the phosphorylation of FAK and the formation of focal adhesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401391     DOI: 10.1189/jlb.0908581

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  21 in total

1.  Intracellular HMGB1 negatively regulates efferocytosis.

Authors:  Sami Banerjee; Andressa de Freitas; Arnaud Friggeri; Jaroslaw W Zmijewski; Gang Liu; Edward Abraham
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 2.  Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.

Authors:  Yiting Tang; Xin Zhao; Daniel Antoine; Xianzhong Xiao; Haichao Wang; Ulf Andersson; Timothy R Billiar; Kevin J Tracey; Ben Lu
Journal:  Antioxid Redox Signal       Date:  2016-02-05       Impact factor: 8.401

3.  The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1.

Authors:  Richard R Kew; Marianna Penzo; David M Habiel; Kenneth B Marcu
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

4.  Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis.

Authors:  J Xu; Y Jiang; J Wang; X Shi; Q Liu; Z Liu; Y Li; M J Scott; G Xiao; S Li; L Fan; T R Billiar; M A Wilson; J Fan
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

5.  TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.

Authors:  Deepak Mittal; Fabiana Saccheri; Emilie Vénéreau; Tobias Pusterla; Marco E Bianchi; Maria Rescigno
Journal:  EMBO J       Date:  2010-06-04       Impact factor: 11.598

Review 6.  Armed response: how dying cells influence T-cell functions.

Authors:  Thomas A Ferguson; Jayoung Choi; Douglas R Green
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

7.  Low-intensity pulsed ultrasound promotes chondrogenic progenitor cell migration via focal adhesion kinase pathway.

Authors:  Kee W Jang; Lei Ding; Dongrim Seol; Tae-Hong Lim; Joseph A Buckwalter; James A Martin
Journal:  Ultrasound Med Biol       Date:  2014-03-04       Impact factor: 2.998

8.  Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected].

Authors:  Marianna Penzo; Raffaella Molteni; Tomomi Suda; Sylvia Samaniego; Angela Raucci; David M Habiel; Frederick Miller; Hui-Ping Jiang; Jun Li; Ruggero Pardi; Roberta Palumbo; Eleonora Olivotto; Richard R Kew; Marco E Bianchi; Kenneth B Marcu
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

Review 9.  The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.

Authors:  Daniel J Weber; Yohance M Allette; David S Wilkes; Fletcher A White
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

Review 10.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.